US04317A1079
US04317A1079
Artiva Biotherapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | 251.000 | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 89.810.000 | 67.533.000 | 33.0% | |
| Operating Income | -89.810.000 | -67.282.000 | 33.5% |
| Pretax Income | -83.865.000 | -58.179.000 | 44.1% |
| Net Income Common Stockholders | -83.865.000 | -58.179.000 | 44.1% |
| -- | -- | -- | |
| -- | -- | -- |